RE:RE:Once an IND is submitted, the FDA has 30 days to objectThat's indeed 30 calendar days, as per the FDA web site.
Once the IND is submitted, the sponsor must wait 30 calendar days before initiating any clinical trials. During this time, FDA has an opportunity to review the IND for safety to assure that research subjects will not be subjected to unreasonable risk.